Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain NVAX message board posts where the ticker symbol NVAX has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest NVAX SEC Filings

Filings Format Description Filing Date File/Film Number
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001144204-18-058373 (34 Act)  Size: 95 KB
2018-11-08 000-26770
181169950
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001144204-18-057994 (34 Act)  Size: 6 MB
2018-11-07 000-26770
181166799
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-056944 Size: 5 KB
2018-11-02
3  Documents Initial statement of beneficial ownership of securities
Acc-no: 0001209191-18-056941 Size: 5 KB
2018-11-02
8-K  Documents Current report, items 5.02 and 9.01
Acc-no: 0001144204-18-057051 (34 Act)  Size: 59 KB
2018-11-02 000-26770
181157380
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001144204-18-043309 (34 Act)  Size: 117 KB
2018-08-09 000-26770
181005340
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001144204-18-042849 (34 Act)  Size: 5 MB
2018-08-08 000-26770
181001848
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-044767 Size: 4 KB
2018-08-01
S-8  Documents Securities to be offered to employees in employee benefit plans
Acc-no: 0001144204-18-041390 (33 Act)  Size: 84 KB
2018-08-01 333-226498
18985416
8-K  Documents Current report, item 1.01
Acc-no: 0001144204-18-039633 (34 Act)  Size: 19 KB
2018-07-24 000-26770
18966693
More NVAX SEC Filings


Related news from
Mon, 12 Nov 2018
21:05:00 +0000
Novavax Expands Leadership with Several Key Management Promotions
Novavax, Inc. (NVAX) today announced several management promotions. “We are pleased to announce several key management promotions to further support the advancement of our company and its lead clinical programs into commercial stage," said Stanley Erck, President and Chief Executive Officer of Novavax, Inc. “These individuals have worked closely with our senior leadership team and have made significant contributions to ensure we drive our ResVax and NanoFlu programs towards licensure.
Mon, 12 Nov 2018
18:44:16 +0000
Does Novavax Inc’s (NASDAQ:NVAX) CEO Pay Reflect Performance?
Stan Erck has been the CEO of Novavax Inc (NASDAQ:NVAX) since 2011. First, this article will compare CEO compensation with compensation at similar sized companies. Then we’ll look at a<div><a class="permalink" href="https://simplywall.st/news/yahoo-post/does-novavax-incs-nasdaqnvax-ceo-pay-reflect-performance/">Read More...</a></div>
Thu, 08 Nov 2018
19:20:04 +0000
What Novavax needs for success as it advances blockbuster vaccine candidates
Novavax is a few months away from results for its two lead vaccine programs — and it's taking steps “to enable us to launch our products as soon as possible post licensure,” CEO Stanley Erck said on a Wednesday earnings call.
Thu, 08 Nov 2018
02:31:46 +0000
Edited Transcript of NVAX earnings conference call or presentation 7-Nov-18 9:30pm GMT
Q3 2018 Novavax Inc Earnings Call
Thu, 08 Nov 2018
01:00:01 +0000
Novavax (NVAX) Reports Q3 Loss, Lags Revenue Estimates
Novavax (NVAX) delivered earnings and revenue surprises of 0.00% and -23.91%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Wed, 07 Nov 2018
23:55:53 +0000
Novavax: 3Q Earnings Snapshot
The Gaithersburg, Maryland-based company said it had a loss of 12 cents per share. The results matched Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
Wed, 07 Nov 2018
21:05:00 +0000
Novavax Reports Third Quarter 2018 Financial Results
Company to Host Conference Call Today at 4:30 p.m. ET GAITHERSBURG, Md., Nov. 07, 2018 -- Novavax, Inc., (Nasdaq: NVAX) today announced its financial results and operational.
Wed, 07 Nov 2018
12:20:07 +0000
Q3 Earnings Outlook For Novavax
On Wednesday, Nov. 7, Novavax, Inc. (NASDAQ: NVAX ) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release. Earnings and Revenue Wall ...
Fri, 02 Nov 2018
22:50:10 +0000
Novavax (NVAX) Gains As Market Dips: What You Should Know
Novavax (NVAX) closed at $1.92 in the latest trading session, marking a +1.05% move from the prior day.
Thu, 01 Nov 2018
20:15:00 +0000
Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 7, 2018
GAITHERSBURG, Md., Nov. 01, 2018 -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its third quarter 2018 financial and operating results following the close of.
Thu, 01 Nov 2018
20:05:00 +0000
Novavax Appoints Rachel King to Board of Directors
GAITHERSBURG, Md., Nov. 01, 2018 -- Novavax, Inc., (Nasdaq: NVAX) today announced the appointment of Rachel King, Co-Founder and Chief Executive Officer of GlycoMimetics, Inc.,.
Wed, 31 Oct 2018
14:51:02 +0000
What's in the Cards for Novavax (NVAX) This Earnings Season?
Investors are looking forward to Novavax's (NVAX) updates on its pipeline candidates when it reports third-quarter 2018 results.
Wed, 24 Oct 2018
12:25:00 +0000
Consolidated Research: 2018 Summary Expectations for Novavax, Caesars Entertainment, SeaWorld Entertainment, LendingTree, CVS Health, and TherapeuticsMD — Fundamental Analysis, Key Performance Indications
NEW YORK, Oct. 24, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Mon, 15 Oct 2018
12:00:00 +0000
Novavax Shares Gain as its Lead Compounds Move Forward, Analysts Review and Target
NEW YORK, NY / ACCESSWIRE / October 15, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Novavax, Inc. (NVAX), a biotechnology company focused on the discovery and development of innovative vaccines to prevent serious respiratory diseases. The company's products are targeted for worldwide markets and its core commercial team is already laying the groundwork before launching with government policymakers, provider, payers, associations, advocates and opinion leaders in advance of regulatory approval.
Sun, 14 Oct 2018
10:32:00 +0000
3 Top Small-Cap Stocks to Buy in October
Big rewards can be found in small packages.
Wed, 10 Oct 2018
22:44:00 +0000
Top 3 Healthcare Penny Stocks for 2018
The healthcare industry can be precarious for stocks of large companies, much less penny stocks. None of these are new companies – they have made progress in developing products and finding the marketing outlets that are needed to sustain them. Because of the higher risk, investors should continuously perform due diligence.
Wed, 10 Oct 2018
17:59:00 +0000
Here's Why Novavax Gained 20.5% in September
A Wall Street analyst turned bullish -- and the market responded in kind. But investors may want to consider the binary nature of this biopharma stock.
Wed, 10 Oct 2018
14:30:00 +0000
Major Biotech Announcements Moving the Market
HENDERSON, NV / ACCESSWIRE / October 10, 2018 / The biotech market is moved by events and announcements. There are a few major events currently impacting the companies highlighted below. Propanc Biopharma, ...
Tue, 09 Oct 2018
11:31:59 +0000
Novavax’s ResVax Vaccine Could Be Blockbuster Market Opportunity
According to Novavax’s Q2 2018 earnings conference call, ~3.9 million babies are born annually in the United States. About 70% of them are afflicted with RSV (respiratory syncytial virus) before the age of one year. Novavax (NVAX) thus expects all infants up to six months of age to be exposed to RSV.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "This is one of the brightest and most generous groups you will ever come across. While I firmly believe everyone has something to contribute to the collective wisdom, this is pretty much a left-brain group. Facts, evidence, and reasoned argument will earn you respect, even if some disagree with you." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards